Cargando…
Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707968/ https://www.ncbi.nlm.nih.gov/pubmed/28676972 http://dx.doi.org/10.1007/s10637-017-0479-3 |
| _version_ | 1783445934412136448 |
|---|---|
| author | Infante, Jeffrey R. Cohen, Roger B. Kim, Kevin B. Burris, Howard A. Curt, Gregory Emeribe, Ugochi Clemett, Delyth Tomkinson, Helen K. LoRusso, Patricia M. |
| author_facet | Infante, Jeffrey R. Cohen, Roger B. Kim, Kevin B. Burris, Howard A. Curt, Gregory Emeribe, Ugochi Clemett, Delyth Tomkinson, Helen K. LoRusso, Patricia M. |
| author_sort | Infante, Jeffrey R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6707968 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67079682019-09-06 Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors Infante, Jeffrey R. Cohen, Roger B. Kim, Kevin B. Burris, Howard A. Curt, Gregory Emeribe, Ugochi Clemett, Delyth Tomkinson, Helen K. LoRusso, Patricia M. Invest New Drugs Erratum Springer US 2017-07-05 2017 /pmc/articles/PMC6707968/ /pubmed/28676972 http://dx.doi.org/10.1007/s10637-017-0479-3 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. |
| spellingShingle | Erratum Infante, Jeffrey R. Cohen, Roger B. Kim, Kevin B. Burris, Howard A. Curt, Gregory Emeribe, Ugochi Clemett, Delyth Tomkinson, Helen K. LoRusso, Patricia M. Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors |
| title | Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors |
| title_full | Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors |
| title_fullStr | Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors |
| title_full_unstemmed | Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors |
| title_short | Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors |
| title_sort | erratum to: a phase i dose-escalation study of selumetinib in combination with erlotinib or temsirolimus in patients with advanced solid tumors |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707968/ https://www.ncbi.nlm.nih.gov/pubmed/28676972 http://dx.doi.org/10.1007/s10637-017-0479-3 |
| work_keys_str_mv | AT infantejeffreyr erratumtoaphaseidoseescalationstudyofselumetinibincombinationwitherlotinibortemsirolimusinpatientswithadvancedsolidtumors AT cohenrogerb erratumtoaphaseidoseescalationstudyofselumetinibincombinationwitherlotinibortemsirolimusinpatientswithadvancedsolidtumors AT kimkevinb erratumtoaphaseidoseescalationstudyofselumetinibincombinationwitherlotinibortemsirolimusinpatientswithadvancedsolidtumors AT burrishowarda erratumtoaphaseidoseescalationstudyofselumetinibincombinationwitherlotinibortemsirolimusinpatientswithadvancedsolidtumors AT curtgregory erratumtoaphaseidoseescalationstudyofselumetinibincombinationwitherlotinibortemsirolimusinpatientswithadvancedsolidtumors AT emeribeugochi erratumtoaphaseidoseescalationstudyofselumetinibincombinationwitherlotinibortemsirolimusinpatientswithadvancedsolidtumors AT clemettdelyth erratumtoaphaseidoseescalationstudyofselumetinibincombinationwitherlotinibortemsirolimusinpatientswithadvancedsolidtumors AT tomkinsonhelenk erratumtoaphaseidoseescalationstudyofselumetinibincombinationwitherlotinibortemsirolimusinpatientswithadvancedsolidtumors AT lorussopatriciam erratumtoaphaseidoseescalationstudyofselumetinibincombinationwitherlotinibortemsirolimusinpatientswithadvancedsolidtumors |